The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT ID: NCT06341062
Last Updated: 2025-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
44 participants
OBSERVATIONAL
2024-04-15
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To explore the quantitative parameters of contrast-enhanced ultrasound which can reflect the changes of renal microcirculation.
2. To explore the relationship between renal microcirculation and systemic hemodynamics.
3. To explore the value of renal microflow changes quantitatively evaluated by contrast-enhanced ultrasound in predicting renal function recovery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Diagnostic Value of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT06353659
Ultrasound to Evaluate Acute Kidney Injury
NCT06241417
Bedside Renal Ultrasound Assessment in Patients With Acute Kidney Injury
NCT06156098
Diagnostic Value of Urinary Indices in Differentiating Pre-renal and Renal Acute Kidney Injury
NCT02376712
Clinical Application of Quantitative Ultrasonographic Analysis in Early Kidney Injury
NCT05662774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients recovering before hospital discharge
Recovery is defined as a return to normal serum creatinine and urine volume or more than 50% improvement in serum creatinine and/or urine volume from baseline
No interventions assigned to this group
Patients not recovering before hospital discharge
Non-recovery is defined as no significant improvement or further increase in serum creatinine and/or urine volume, the need for dialysis, or death.
Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound
Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound before hospital discharge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound
Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound before hospital discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* AKI was diagnosed \< 24 hours after first admission to intensive care unit (ICU) and the expected length of stay in ICU ≥48 hours;
* Meet Kidney Disease Improving Global Outcomes (KDIGO) 2012 diagnostic criteria for acute kidney injury;
* Contrast-enhanced ultrasound was performed within 24 hours after diagnosis of acute kidney injury (AKI).
Exclusion Criteria
* Kidney transplantation or renal malignancy;
* Terminal stage of malignant tumor;
* Pregnancy;
* Renal artery stenosis or renal vein thrombosis;
* Allergy to contrast agent SonoVue(BraccoSpA, Milan, Italy) or its components, or the presence of severe cardiopulmonary insufficiency (e.g., right-to-left shunt heart disease or pulmonary systolic blood pressure \>90mmHg).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cui Ligang
Chief Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ligang Cui, Dr
Role: PRINCIPAL_INVESTIGATOR
Department of Ultrasound, Peking University Third Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ultrasound Diagnosis, Peking University Third Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M2024078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.